A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)
- 作者Tianhong Li, Mengye Guo, William J. Gradishar, Joseph A. Sparano, Edith A. Perez, Molin Wang, George W. Sledge
- 卷第134卷
- 期第1期
- 印刷ISSN0167-6806
- 电子ISSN1573-7217
- 文件大小301.20KB
- 发表时间2012-07
- DOI10.1007/s10549-012-2071-z
- 页码345-352
同作者推荐
Variations in Nursing Practice EnvironmentsLake, Eileen T.; Friese, Christopher R. · Nursing Research · 2006
Precision Medicine in Breast Cancer CareKurian, Allison W.; Friese, Christopher R. · JAMA Oncology · 2015
Prevention of Infection in Patients With CancerChristopher R. Friese · 2007
Nurse-Physician Relationships in Ambulatory Oncology SettingsChristopher R. Friese; Milisa Manojlovich · 2012
With cost pressures up, will nurses be targeted again?Christopher R. Friese · 2006
Nurse Practice Environments and Outcomes: Implications for Oncology NursingFriese, Christopher R. · Oncology Nursing Forum · 2005
Revisiting Nursing’s Effect on Surgical Quality and CostGhaferi, Amir A.; Friese, Christopher R. · JAMA Surgery · 2016